SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 18 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $3,384,000 | +77.3% | 19,583 | +17.9% | 0.01% | +50.0% |
| Q4 2014 | $1,909,000 | +609.7% | 16,608 | +862.8% | 0.00% | +300.0% |
| Q3 2014 | $269,000 | -99.3% | 1,725 | -99.4% | 0.00% | -98.7% |
| Q2 2014 | $36,562,000 | +262.8% | 296,410 | +204.8% | 0.08% | +229.2% |
| Q1 2014 | $10,077,000 | +2714.8% | 97,258 | +2343.7% | 0.02% | +2300.0% |
| Q4 2013 | $358,000 | -7.7% | 3,980 | -31.3% | 0.00% | 0.0% |
| Q3 2013 | $388,000 | +15.8% | 5,797 | +14.5% | 0.00% | 0.0% |
| Q2 2013 | $335,000 | +28.4% | 5,065 | -0.8% | 0.00% | 0.0% |
| Q1 2013 | $261,000 | +18.6% | 5,106 | -6.3% | 0.00% | 0.0% |
| Q4 2012 | $220,000 | -3.5% | 5,448 | +1.1% | 0.00% | 0.0% |
| Q3 2012 | $228,000 | -26.0% | 5,389 | -4.9% | 0.00% | 0.0% |
| Q2 2012 | $308,000 | – | 5,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MONETARY MANAGEMENT GROUP INC | 300 | $52,000 | 0.02% |